Gemmer Asset Management’s UROLOGIX INC ULGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-40,321
Closed -$1K 1506
2021
Q2
$1K Hold
40,321
﹤0.01% 1491
2021
Q1
$0 Hold
40,321
﹤0.01% 1551
2020
Q4
$0 Sell
40,321
-200
-0.5% ﹤0.01% 1498
2020
Q3
$0 Hold
40,521
﹤0.01% 1415
2020
Q2
$0 Hold
40,521
﹤0.01% 1394
2020
Q1
$0 Hold
40,521
﹤0.01% 1510
2019
Q4
$0 Hold
40,521
﹤0.01% 1484
2019
Q3
$0 Hold
40,521
﹤0.01% 1524
2019
Q2
$0 Hold
40,521
﹤0.01% 1489
2019
Q1
$0 Hold
40,521
﹤0.01% 1472
2018
Q4
$0 Hold
40,521
﹤0.01% 1512
2018
Q3
$0 Hold
40,521
﹤0.01% 1481
2018
Q2
$3K Hold
40,521
﹤0.01% 1261
2018
Q1
$0 Hold
40,521
﹤0.01% 1541
2017
Q4
$0 Hold
40,521
﹤0.01% 1298
2017
Q3
$0 Hold
40,521
﹤0.01% 1320
2017
Q2
$0 Hold
40,521
﹤0.01% 1301
2017
Q1
$0 Buy
+40,521
New ﹤0.01% 1281
2016
Q4
Sell
-40,521
Closed 1281
2016
Q3
$0 Hold
40,521
﹤0.01% 1295
2016
Q2
$0 Hold
40,521
﹤0.01% 1320
2016
Q1
$0 Hold
40,521
﹤0.01% 1370
2015
Q4
$0 Hold
40,521
﹤0.01% 1348
2015
Q3
$1K Hold
40,521
﹤0.01% 1251
2015
Q2
$4K Hold
40,521
﹤0.01% 974
2015
Q1
$3K Buy
+40,521
New +$3K ﹤0.01% 1127
2014
Q4
Sell
-40,521
Closed -$4K 1514
2014
Q3
$4K Buy
+40,521
New +$4K ﹤0.01% 1002

Gemmer Asset Management's ULGX Position: Q3 2021 in Review

Gemmer Asset Management sold out of UROLOGIX INC (ULGX) in Q3 2021, closing a stake of 40,321 shares — an estimated $1K sold.

Gemmer Asset Management first reported a position in ULGX in Q3 2014 and held it in 26 quarters. The position peaked at $4K in Q2 2015. 0 funds tracked by Wall St. Rank hold ULGX as of Q3 2021.

  • Gemmer Asset Management reported no remaining UROLOGIX INC position as of Q3 2021 after selling out during the quarter.
  • Gemmer Asset Management sold 40,321 UROLOGIX INC shares in Q3 2021, an estimated $1K.
  • Gemmer Asset Management first reported a position in UROLOGIX INC in Q3 2014 and held it in 26 quarters.
  • Gemmer Asset Management's UROLOGIX INC position peaked at $4K in Q2 2015.
  • 0 funds tracked by Wall St. Rank held UROLOGIX INC as of Q3 2021.

Based on Gemmer Asset Management's 13F filing for Q3 2021, filed 19 Oct 2021.